Compare Heartflow Inc. Common Stock (HTFL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heartflow Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Heartflow Inc. Common Stock trades at $48.78 (market cap $4.30B), while Vir Biotechnology Inc. Common Stock trades at $10.49 (market cap $1.76B). The key difference: Heartflow Inc. Common Stock is far larger — about 2.4× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is more actively traded (2,764,948 versus 1,616,039). Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| HTFL | VIR | |
|---|---|---|
Market Cap | $4.30B | $1.76B |
Volume | 1,616,039 | 2,764,948 |
Sector | Health | Health |
52-Week High | $52.21 | $11.78 |
52-Week Low | $20.49 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.17B | $1.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heartflow Inc. Common Stock
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
